For research use only. We do not sell to patients.

SJ1008030

Biological Activity：SJ1008030 (compound 8) is a JAK2 PROTAC which selectively degrades JAK2. SJ1008030 inhibits MHH–CALL-4 cells with an EC₅₀ of 5.4 nM and an IC₅₀ of 32.09 nM. SJ1008030 can be used for the research of leukemia.

Research Area：Cancer

Targets：JAK|PROTACs

Related Small Molecules:AZ-3;PROTAC Sirt2 Degrader-1;DB0614;JAK3/BTK-IN-1;AT9283;Benzene hexabromide;PROTAC VEGFR-2 degrader-2;(E/Z)-Zotiraciclib;dTAGV-1-NEG;CCT367766 formic;JAK-IN-10;Baricitinib-d3;JAK3-IN-6;HDAC6 degrader-1;PROTAC Axl Degrader 2;PhosTAC7;MS98;JPS014;Coumermycin A1;Deucravacitinib;PROTAC PARP1 degrader;MD-224;Momelotinib-3,3,5,5-d4;FKBP12 PROTAC dTAG-7;SJ10542;MS8815;RIP2 Kinase Inhibitor 4

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

About Us:

• MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
• Structurally and synthetically diverse biologically active compounds；
•  roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
• We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
• Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；

Structurally and synthetically diverse biologically active compounds；

• Customized order volume ranging from milligrams to kilograms scale；

We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.